TY  - CHAP
M1  - Book, Section
TI  - T-Cell Lymphomas
A1  - Chihara, Dai
A1  - Wang, Casey
A1  - Duvic, Madeleine
A1  - Medeiros, L. Jeffrey
A1  - Oki, Yasuhiro
A2  - Kantarjian, Hagop M.
A2  - Wolff, Robert A.
PY  - 2016
T2  - The MD Anderson Manual of Medical Oncology, 3e
AB  - Peripheral  T-cell  lymphoma  (PTCL)  is  a  heterogeneous  group  of  lymphomas  derived  from  a  mature  T  cell  (Fig.  9-1).  Currently,  the  World  Health  Organization  (WHO)  classification  combines  mature  T-  and  natural  killer  (NK)-cell  neoplasms  under  the  umbrella  term  PTCL,  and  the  category  is  composed  of  23  different  entities  (Table  9-1),  based  on  the  different  morphologic,  phenotypic,  molecular,  and  clinical  features,  including  disease  site  (1).  Most  PTCLs  lack  distinct  genetic  or  biologic  alterations  that  are  seen  in  B-cell  lymphomas,  such  as  t(14;18)  in  follicular  lymphoma  and  t(11;14)  in  mantle  cell  lymphoma.  Compared  with  B-cell  lymphomas,  many  types  of  PTCL  develop  not  in  lymph  nodes,  but  in  specific  extranodal  sites  such  as  extranodal  NK/T-cell  lymphoma,  nasal  type  (ENKL)  in  the  nasal  cavity,  enteropathy-associated  T-cell  lymphoma  (EATL)  in  the  small  intestine,  and  hepatosplenic  T-cell  lymphoma  (HSTL)  in  the  liver  and  spleen.  
SN  - 
PB  - McGraw-Hill Medical
CY  - New York, NY
Y2  - 2024/04/19
UR  - hemonc.mhmedical.com/content.aspx?aid=1126740719
ER  -